Boiron SA (BOI) Stock Price & News

BOI:EPA

Boiron SA

26,00 €

+1,56%

(+0,40) 1D

4 սեպ, 17:37:44 GMT+2 · EUR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for BOI...

Open

25,60 €

High

26,00 €

Low

25,40 €

Mkt. cap

438,72 մլն

Avg. vol.

2,10 հզր

Volume

1,85 հզր

P/E ratio

13,83

52-wk high

32,25 €

52-wk low

21,55 €

EPS

1,88 €

Shares outstanding

17,55 մլն

No. of employees

2 հզր

Open

25,60 €

High

26,00 €

Low

25,40 €

Mkt. cap

438,72 մլն

Avg. vol.

2,10 հզր

Volume

1,85 հզր

P/E ratio

13,83

52-wk high

32,25 €

52-wk low

21,55 €

EPS

1,88 €

Shares outstanding

17,55 մլն

No. of employees

2 հզր

Related stocks

Etablissements Maurel et Prom SA

7,88 €

-3,37%

Profile

Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia

About Boiron SA

CEO-

Employees2,5 հզր

Founded07 հնս, 1932 թ.

Headquarters-

Sector-

Websiteboiron.fr

All values in EUR	2025 թ. մրտ	2025 թ. հնս	2025 թ. սեպ	2025 թ. դեկ
Revenue	122,82 մլն	122,82 մլն	127,73 մլն	127,73 մլն
Cost of goods sold	32,29 մլն	32,29 մլն	35,40 մլն	35,40 մլն
Cost of revenue	32,29 մլն	32,29 մլն	35,40 մլն	35,40 մլն
Research and development expenses	1,27 մլն	1,27 մլն	1,56 մլն	1,56 մլն
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	79,15 մլն	79,15 մլն	79,26 մլն	79,26 մլն
Operating expense	79,55 մլն	79,55 մլն	77,52 մլն	77,52 մլն
Total operating expenses	111,85 մլն	111,85 մլն	112,92 մլն	112,92 մլն
Operating income	10,98 մլն	10,98 մլն	14,81 մլն	14,81 մլն
Other non operating income	-3,01 մլն	-3,01 մլն	-1,13 մլն	-1,13 մլն
EBT including unusual items	7,61 մլն	7,61 մլն	13,82 մլն	13,82 մլն
EBT excluding unusual items	7,60 մլն	7,60 մլն	13,16 մլն	13,16 մլն
Income tax expense	1,93 մլն	1,93 մլն	3,18 մլն	3,18 մլն
Effective tax rate	25,37%	25,37%	22,99%	22,99%
Other operating expenses	-864,50 հզր	-864,50 հզր	-3,30 մլն	-3,30 մլն
Net income	5,68 մլն	5,68 մլն	10,64 մլն	10,64 մլն
Net profit margin	4,63%	4,63%	8,33%	8,33%
Earnings per share	-	-	-	-
Interest and investment income	613,50 հզր	613,50 հզր	653,00 հզր	653,00 հզր
Interest expense	-220,50 հզր	-220,50 հզր	-335,00 հզր	-335,00 հզր
Net interest expenses	393,00 հզր	393,00 հզր	318,00 հզր	318,00 հզր
Depreciation and amortization charges	-	-	-	-
EBITDA	16,52 մլն	16,52 մլն	18,06 մլն	18,06 մլն
Gain or loss from assets sale	-	-	-446,00 հզր	-446,00 հզր

Finance

Ask anything